Tag: AHA 2026
Cleerly trial shows AI plaque readings change how chest pain gets treated
Cleerly's PARAMOUNT trial, the first randomized test of AI-guided plaque analysis against stress-testing, met its primary endpoint at AHA 2026.…
Cleerly's PARAMOUNT trial, the first randomized test of AI-guided plaque analysis against stress-testing, met its primary endpoint at AHA 2026.…